These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33167948)

  • 21. Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression: A Systematic Review and Meta-analysis.
    Dai L; Chen L; Wang W
    J Nerv Ment Dis; 2020 Apr; 208(4):269-276. PubMed ID: 32221179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
    Li Y; Hai S; Zhou Y; Dong BR
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.
    Webster L; Groskreutz D; Grinbergs-Saull A; Howard R; O'Brien JT; Mountain G; Banerjee S; Woods B; Perneczky R; Lafortune L; Roberts C; McCleery J; Pickett J; Bunn F; Challis D; Charlesworth G; Featherstone K; Fox C; Goodman C; Jones R; Lamb S; Moniz-Cook E; Schneider J; Shepperd S; Surr C; Thompson-Coon J; Ballard C; Brayne C; Burke O; Burns A; Clare L; Garrard P; Kehoe P; Passmore P; Holmes C; Maidment I; Murtagh F; Robinson L; Livingston G
    Health Technol Assess; 2017 May; 21(26):1-192. PubMed ID: 28625273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    D'Onofrio G; Nabavi SM; Sancarlo D; Greco A; Pieretti S
    Curr Neuropharmacol; 2021; 19(9):1606-1616. PubMed ID: 33441068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memantine for dementia.
    McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease.
    Lansdall CJ; McDougall F; Butler LM; Delmar P; Pross N; Qin S; McLeod L; Zhou X; Kerchner GA; Doody RS
    J Prev Alzheimers Dis; 2023; 10(1):9-18. PubMed ID: 36641605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chinese Herbal Medicine for Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes.
    Dong L; May BH; Feng M; Hyde AJ; Tan HY; Guo X; Zhang AL; Lu C; Xue CC
    Phytother Res; 2016 Oct; 30(10):1592-1604. PubMed ID: 27416935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study.
    Lu C; Ke L; Li J; Zhao H; Lu T; Mentis AFA; Wang Y; Wang Z; Polissiou MG; Tang L; Tang H; Yang K
    Phytomedicine; 2021 Oct; 91():153699. PubMed ID: 34419735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.
    Akhondzadeh S; Shafiee Sabet M; Harirchian MH; Togha M; Cheraghmakani H; Razeghi S; Hejazi SS; Yousefi MH; Alimardani R; Jamshidi A; Rezazadeh SA; Yousefi A; Zare F; Moradi A; Vossoughi A
    Psychopharmacology (Berl); 2010 Jan; 207(4):637-43. PubMed ID: 19838862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal clinically important difference in Alzheimer's disease: Rapid review.
    Muir RT; Hill MD; Black SE; Smith EE
    Alzheimers Dement; 2024 May; 20(5):3352-3363. PubMed ID: 38561021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 fatty acids for the treatment of dementia.
    Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.
    Yang G; Wang Y; Tian J; Liu JP
    PLoS One; 2013; 8(9):e74916. PubMed ID: 24086396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal protein attenuating compounds for the treatment of Alzheimer's dementia.
    Sampson EL; Jenagaratnam L; McShane R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005380. PubMed ID: 24563468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saffron (Crocus sativus L.) extract attenuates chronic scopolamine-induced cognitive impairment, amyloid beta, and neurofibrillary tangles accumulation in rats.
    Patel KS; Dharamsi A; Priya M; Jain S; Mandal V; Girme A; Modi SJ; Hingorani L
    J Ethnopharmacol; 2024 May; 326():117898. PubMed ID: 38341114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metal protein attenuating compounds for the treatment of Alzheimer's dementia.
    Sampson EL; Jenagaratnam L; McShane R
    Cochrane Database Syst Rev; 2012 May; 5(5):CD005380. PubMed ID: 22592705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms.
    Han S; Cao Y; Wu X; Xu J; Nie Z; Qiu Y
    Phytother Res; 2024 May; 38(5):2276-2302. PubMed ID: 38424688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Isaac MG; Clark AR; Rusted J; Tabet N
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD002854. PubMed ID: 23152215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.